Patents Assigned to IGC BIO, INC.
  • Publication number: 20210335455
    Abstract: The invention relates to system and method for generating an antibody library. Specifically, the invention relates to a computer-implemented system and method for generating a library of antibodies based on a predetermined epitope.
    Type: Application
    Filed: February 1, 2021
    Publication date: October 28, 2021
    Applicant: IGC BIO, INC.
    Inventors: Lior ZIMMERMAN, Dror BARAN
  • Patent number: 11127483
    Abstract: This disclosure presents methods for antibody structure prediction and design. We utilize the growing number of antibody structures and sequences are used with powerful protein modeling methods to design and predict antibody structural models up to sub-angstrom accuracy. The invention also relates to systems and methods for generating an antibody library. Specifically, the invention relates to computer-implemented systems and methods for generating an antibody library for a predetermined epitope. The invention further relates to determining structural models of the interface between an antibody and its antigen. The invention also relates to determining structural models of an unbound complementarity determining region of an antibody.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: September 21, 2021
    Assignee: IGC BIO, INC.
    Inventors: Dror Baran, Lior Zimmerman
  • Publication number: 20200291366
    Abstract: The present invention provides enzymes that have been optimized by implementation of Protein Repair One Stop Shop (PROSS), an algorithm that generates protein design(s) for enhanced stability without changing either enzymatic properties or enzyme active site conformation of the respective enzyme. The protein design(s) generated by PROSS introduce mutations to the amino acid sequence of a wild-type protein, resulting in a mutated amino acid sequence that encodes a variant of the wild-type enzyme, i.e., “an enzyme variant”, which has an enhanced stability, core packing, surface polarity and backbone rigidity, a higher functional expression, and/or a combination thereof, compared to the stability core packing, surface polarity and backbone rigidity, functional expression and/or a combination thereof, of the wild-type enzyme.
    Type: Application
    Filed: September 12, 2018
    Publication date: September 17, 2020
    Applicant: IGC BIO, INC.
    Inventors: Lior ZIMMERMAN, Dror BARAN
  • Publication number: 20200255813
    Abstract: The present invention provides enzymes that have been optimized by implementation of Protein Repair One Stop Shop (PROSS), an algorithm that generates protein design(s) for enhanced stability without changing either enzymatic properties or enzyme active site conformation of the respective enzyme. The protein design(s) generated by PROSS introduce mutations to the amino acid sequence of a wild-type protein, resulting in a mutated amino acid sequence that encodes a variant of the wild-type enzyme, i.e., an enzyme variant, which has an enhanced stability, core packing, surface polarity and backbone rigidity, a higher functional expression, and/or a combination thereof, compared to the stability core packing, surface polarity and backbone rigidity, functional expression and/or a combination thereof, of the wild-type enzyme.
    Type: Application
    Filed: July 9, 2018
    Publication date: August 13, 2020
    Applicant: IGC BIO, INC.
    Inventors: Lior ZIMMERMAN, Dror BARAN
  • Publication number: 20200207844
    Abstract: This disclosure relates to antibodies and antigen-binding fragments that bind specifically to Vascular endothelial growth factor (VEGF), and prophylactic, diagnostic, and therapeutic methods of using the same.
    Type: Application
    Filed: September 11, 2018
    Publication date: July 2, 2020
    Applicant: IGC BIO, INC.
    Inventors: Dror BARAN, Lior ZIMMERMAN
  • Publication number: 20200126640
    Abstract: Methods for computational affinity maturation are described wherein a candidate antibody sequence is optimized for affinity, stability, or both, first utilizing computational saturation mutagenesis to identify and mutations at those positions that satisfy a predefined first threshold of affinity score or stability score, generating sequences comprising all combinations of the mutations at each position, computing the affinity score, stability score, or both and ranking the variant antibody sequences according to a predefined second threshold, then from the affinity score or stability score of all generated sequences identify the optimized antibody sequences. The method is ideally carried out on multiple CPUs where a server generates the sequences, the CPUs evaluate the affinity or stability score, reports the results to the server, which ranks all of the data from the CPUs to identify the optimal candidates.
    Type: Application
    Filed: October 17, 2019
    Publication date: April 23, 2020
    Applicant: IGC BIO, INC.
    Inventor: Lior ZIMMERMAN
  • Publication number: 20190367614
    Abstract: This disclosure relates to antibodies and antigen-binding fragments that bind specifically to Programmed cell death protein 1 (PD-1), and prophylactic, diagnostic, and therapeutic methods of using the same.
    Type: Application
    Filed: January 8, 2019
    Publication date: December 5, 2019
    Applicant: IGC BIO, INC.
    Inventors: Dror BARAN, Lior ZIMMERMAN
  • Publication number: 20180196926
    Abstract: The invention relates to system and method for generating an antibody library. Specifically, the invention relates to a computer-implemented system and method for generating a library of antibodies based on a predetermined epitope.
    Type: Application
    Filed: January 7, 2018
    Publication date: July 12, 2018
    Applicant: IGC BIO, INC.
    Inventors: Lior ZIMMERMAN, Dror Baran
  • Publication number: 20180057961
    Abstract: The invention relates to systems and methods for generating a polypeptide library. Specifically, the invention relates to computer-implemented systems and methods for generating a library of polypeptides, for example, antibodies.
    Type: Application
    Filed: August 24, 2017
    Publication date: March 1, 2018
    Applicant: IGC BIO, INC.
    Inventor: Lior ZIMMERMAN